Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancer

MLA

Hollis RL, et al. “Distinct Implications of Different BRCA Mutations: Efficacy of Cytotoxic Chemotherapy, PARP Inhibition and Clinical Outcome in Ovarian Cancer.” OncoTargets and Therapy, May 2017, pp. 2539–51. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doajarticles..d0f1451fcddcaaf224e4a6aed1f427e7&authtype=sso&custid=ns315887.

APA

Hollis RL, Churchman M, & Gourley C. (2017). Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancer. OncoTargets and Therapy, 2539–2551.

Chicago

Hollis RL, Churchman M, and Gourley C. 2017. “Distinct Implications of Different BRCA Mutations: Efficacy of Cytotoxic Chemotherapy, PARP Inhibition and Clinical Outcome in Ovarian Cancer.” OncoTargets and Therapy, May, 2539–51. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doajarticles..d0f1451fcddcaaf224e4a6aed1f427e7&authtype=sso&custid=ns315887.